|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 43/16 | |
| A61K 31/35 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3108750 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16182813.2 |
| Europos patento paraiškos padavimo data | 2011-03-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 315890 P | 2010-03-19 | US | |
| 315886 P | 2010-03-19 | US | |
| 325814 P | 2010-04-19 | US |
| (72) |
LI, Chiang Jia, US
LEGGETT, David, US
LI, Youzhi, US
LI, Wei, US
|
| (73) |
1Globe Biomedical Co., Ltd.,
8F, Block B, Techart Plaza No.30 Xueyuan Road Haidian District, Beijing 100083,
CN
|
| (54) | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS |
| NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS |